Janet L. Kalesnikoff, Ph.D. - Publications

Affiliations: 
2003 University of British Columbia, Vancouver, Vancouver, BC, Canada 
Area:
Immunology

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Tam SY, Lilla JN, Chen CC, Kalesnikoff J, Tsai M. RabGEF1/Rabex-5 Regulates TrkA-Mediated Neurite Outgrowth and NMDA-Induced Signaling Activation in NGF-Differentiated PC12 Cells. Plos One. 10: e0142935. PMID 26588713 DOI: 10.1371/Journal.Pone.0142935  0.388
2015 Rios EJ, Kalesnikoff J. FcεRI expression and dynamics on mast cells. Methods in Molecular Biology (Clifton, N.J.). 1220: 239-55. PMID 25388255 DOI: 10.1007/978-1-4939-1568-2_15  0.471
2013 Marichal T, Starkl P, Reber LL, Kalesnikoff J, Oettgen HC, Tsai M, Metz M, Galli SJ. A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity. 39: 963-75. PMID 24210352 DOI: 10.1016/J.Immuni.2013.10.005  0.347
2013 Leveson-Gower DB, Sega EI, Kalesnikoff J, Florek M, Pan Y, Pierini A, Galli SJ, Negrin RS. Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells. Blood. 122: 3659-65. PMID 24030387 DOI: 10.1182/Blood-2013-08-519157  0.43
2013 Oka T, Rios EJ, Tsai M, Kalesnikoff J, Galli SJ. Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells. The Journal of Allergy and Clinical Immunology. 132: 922-32.e1-16. PMID 23810240 DOI: 10.1016/J.Jaci.2013.05.004  0.347
2013 Schäfer B, Piliponsky AM, Oka T, Song CH, Gerard NP, Gerard C, Tsai M, Kalesnikoff J, Galli SJ. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. The Journal of Allergy and Clinical Immunology. 131: 541-8.e1-9. PMID 22728083 DOI: 10.1016/J.Jaci.2012.05.009  0.31
2012 Oka T, Kalesnikoff J, Starkl P, Tsai M, Galli SJ. Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 92: 1472-82. PMID 22906983 DOI: 10.1038/Labinvest.2012.116  0.449
2011 Lilla JN, Chen CC, Mukai K, BenBarak MJ, Franco CB, Kalesnikoff J, Yu M, Tsai M, Piliponsky AM, Galli SJ. Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice. Blood. 118: 6930-8. PMID 22001390 DOI: 10.1182/Blood-2011-03-343962  0.444
2011 Kalesnikoff J, Galli SJ. Antiinflammatory and immunosuppressive functions of mast cells. Methods in Molecular Biology (Clifton, N.J.). 677: 207-20. PMID 20941613 DOI: 10.1007/978-1-60761-869-0_15  0.497
2010 Kalesnikoff J, Galli SJ. Anaphylaxis: mechanisms of mast cell activation. Chemical Immunology and Allergy. 95: 45-66. PMID 20519881 DOI: 10.1159/000315937  0.42
2010 Piliponsky AM, Chen CC, Grimbaldeston MA, Burns-Guydish SM, Hardy J, Kalesnikoff J, Contag CH, Tsai M, Galli SJ. Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. The American Journal of Pathology. 176: 926-38. PMID 20035049 DOI: 10.2353/Ajpath.2010.090342  0.418
2010 Leveson-Gower DB, Sega EI, Kalesnikoff J, Florek M, Galli SJ, Negrin R. Mast Cells Reduce Gvhd Severity In Allogeneic Transplantation by Reducing the Proliferation of Conventional T Cells Blood. 116: 243-243. DOI: 10.1182/Blood.V116.21.243.243  0.445
2008 Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nature Immunology. 9: 1215-23. PMID 18936782 DOI: 10.1038/Ni.F.216  0.418
2008 Sly LM, Kalesnikoff J, Lam V, Wong D, Song C, Omeis S, Chan K, Lee CW, Siraganian RP, Rivera J, Krystal G. IgE-induced mast cell survival requires the prolonged generation of reactive oxygen species. Journal of Immunology (Baltimore, Md. : 1950). 181: 3850-60. PMID 18768839 DOI: 10.4049/Jimmunol.181.6.3850  0.62
2008 Rios EJ, Piliponsky AM, Ra C, Kalesnikoff J, Galli SJ. Rabaptin-5 regulates receptor expression and functional activation in mast cells. Blood. 112: 4148-57. PMID 18698003 DOI: 10.1182/Blood-2008-04-152660  0.463
2007 Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nature Immunology. 8: 1095-104. PMID 17767162 DOI: 10.1038/Ni1503  0.392
2007 Kalesnikoff J, Rios EJ, Chen CC, Alejandro Barbieri M, Tsai M, Tam SY, Galli SJ. Roles of RabGEF1/Rabex-5 domains in regulating Fc epsilon RI surface expression and Fc epsilon RI-dependent responses in mast cells. Blood. 109: 5308-17. PMID 17341663 DOI: 10.1182/Blood-2007-01-067363  0.452
2006 Tam SY, Kalesnikoff J, Nakae S, Tsai M, Galli SJ. RabGEF1, a negative regulator of Ras signalling, mast cell activation and skin inflammation. Novartis Foundation Symposium. 271: 115-24; discussion 1. PMID 16605131  0.392
2006 Kalesnikoff J, Rios EJ, Chen CC, Nakae S, Zabel BA, Butcher EC, Tsai M, Tam SY, Galli SJ. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 2659-64. PMID 16533754 DOI: 10.1073/Pnas.0511191103  0.576
2005 Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annual Review of Immunology. 23: 749-86. PMID 15771585 DOI: 10.1146/Annurev.Immunol.21.120601.141025  0.456
2005 Tam S, Kalesnikoff J, Nakae S, Tsai M, Galli SJ. RabGEF1, a Negative Regulator of Ras Signalling, Mast Cell Activation and Skin Inflammation Novartis Foundation Symposium. 271: 115-130. DOI: 10.1002/9780470033449.Ch9  0.483
2004 Sly LM, Rauh MJ, Kalesnikoff J, Song CH, Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity. 21: 227-39. PMID 15308103 DOI: 10.1016/J.Immuni.2004.07.010  0.532
2004 Tam SY, Tsai M, Snouwaert JN, Kalesnikoff J, Scherrer D, Nakae S, Chatterjea D, Bouley DM, Galli SJ. RabGEF1 is a negative regulator of mast cell activation and skin inflammation. Nature Immunology. 5: 844-52. PMID 15235600 DOI: 10.1038/Ni1093  0.483
2004 Hernandez-Hansen V, Smith AJ, Surviladze Z, Chigaev A, Mazel T, Kalesnikoff J, Lowell CA, Krystal G, Sklar LA, Wilson BS, Oliver JM. Dysregulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 100-12. PMID 15210764 DOI: 10.4049/Jimmunol.173.1.100  0.661
2003 Sly LM, Rauh MJ, Kalesnikoff J, Büchse T, Krystal G. SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide. Experimental Hematology. 31: 1170-81. PMID 14662322 DOI: 10.1016/J.Exphem.2003.09.011  0.649
2003 Lam V, Kalesnikoff J, Lee CW, Hernandez-Hansen V, Wilson BS, Oliver JM, Krystal G. IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor. Blood. 102: 1405-13. PMID 12702510 DOI: 10.1182/Blood-2002-10-3176  0.673
2002 Kalesnikoff J, Lam V, Krystal G. SHIP represses mast cell activation and reveals that IgE alone triggers signaling pathways which enhance normal mast cell survival Molecular Immunology. 38: 1201-1206. PMID 12217384 DOI: 10.1016/S0161-5890(02)00064-0  0.64
2002 Takeshita S, Namba N, Zhao JJ, Jiang Y, Genant HK, Silva MJ, Brodt MD, Helgason CD, Kalesnikoff J, Rauh MJ, Humphries RK, Krystal G, Teitelbaum SL, Ross FP. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nature Medicine. 8: 943-9. PMID 12161749 DOI: 10.1038/Nm752  0.595
2002 Leitges M, Gimborn K, Elis W, Kalesnikoff J, Hughes MR, Krystal G, Huber M. Protein kinase C-delta is a negative regulator of antigen-induced mast cell degranulation. Molecular and Cellular Biology. 22: 3970-80. PMID 12024011 DOI: 10.1128/Mcb.22.12.3970-3980.2002  0.664
2002 Huber M, Kalesnikoff J, Reth M, Krystal G. The role of SHIP in mast cell degranulation and IgE-induced mast cell survival. Immunology Letters. 82: 17-21. PMID 12008029 DOI: 10.1016/S0165-2478(02)00012-3  0.652
2002 Kalesnikoff J, Baur N, Leitges M, Hughes MR, Damen JE, Huber M, Krystal G. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity. Journal of Immunology (Baltimore, Md. : 1950). 168: 4737-46. PMID 11971024 DOI: 10.4049/Jimmunol.168.9.4737  0.625
2001 Kalesnikoff J, Huber M, Lam V, Damen JE, Zhang J, Siraganian RP, Krystal G. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity. 14: 801-11. PMID 11420049 DOI: 10.1016/S1074-7613(01)00159-5  0.658
2001 Damen JE, Ware MD, Kalesnikoff J, Hughes MR, Krystal G. SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation. Blood. 97: 1343-51. PMID 11222379 DOI: 10.1182/Blood.V97.5.1343  0.732
2000 Damen J, Ware M, Kalesnikoff J, Krystal G. The proline-rich c-terminus of ship is required for its inhibition of mast cell degranulation Experimental Hematology. 28: 84-85. DOI: 10.1016/S0301-472X(00)00351-9  0.717
Show low-probability matches.